Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “technology evaluations”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,315 records · Page 73

WE-FG-207A-01: Introduction to Dedicated Breast CT - Early Studies

Mammography-based screening has been a valuable imaging tool for the early detection of non-palpable lesions and has contributed to significant reduction in breast cancer associated mortality. However, the breast imaging community recognizes that mammography is not ideal, and in particular is inferior for women with dense breasts. Also, the 2-D projection of a 3-D organ results in tissue superposition contributing to false-positives. The sensitivity of mammography is breast-density dependent. Its sensitivity, especially in dense breasts, is low due to overlapping tissue and the fact that normal breast tissue, benign lesions and breast cancers all have similar “densities”, making lesion detection more difficult. We ideally need 3-D imaging for imaging the 3-D breast. MRI is 3-D, whole breast ultrasound is 3-D, digital breast tomosynthesis is called 3-D but is really “pseudo 3-D” due to poor resolution along the depth-direction. Also, and importantly, we need to be able to administer intravenous contrast agents for optimal imaging, similar to other organ systems in the body. Dedicated breast CT allows for 3-D imaging of the uncompressed breast. In current designs, the patient is positioned prone on the table and the breast is pendant through an aperture and the scan takes approximately 10 seconds [O’Connell et al., AJR 195: 496–509, 2010]. Almost on the heels of the invention of CT itself, work began on the development of dedicated breast CT. These early breast CT systems were used in clinical trials and the results from comparative performance evaluation of breast CT and mammography for 1625 subjects were reported in 1980 [Chang et al., Cancer 46: 939–46, 1980]. However, the technological limitations at that time stymied clinical translation for decades. Subsequent to the landmark article in 2001 [Boone et al., Radiology 221: 657–67, 2001] that demonstrated the potential feasibility in terms of radiation dose, multiple research groups are actively investigating dedicated breast CT. The development of large-area flat-panel detectors with field-of-view sufficient to image the entire breast in each projection enabled development of flat-panel cone-beam breast CT. More recently, the availability of complimentary metal-oxide semiconductor (CMOS) detectors with lower system noise and finer pixel pitch, combined with the development of x-ray tubes with focal spot dimensions similar to mammography systems, has shown improved spatial resolution and could improve visualization of microcalcifications. These technological developments promise clinical translation of low-dose cone-beam breast CT. Dedicated photon-counting breast CT (pcBCT) systems represent a novel detector design, which provide high spatial resolution (∼ 100µm) and low mean glandular dose (MGD). The CdTe-based direct conversion detector technology was previously evaluated and confirmed by simulations and basic experiments on laboratory setups [Kalender et al., Eur Radiol 22: 1–8, 2012]. Measurements of dose, technical image quality parameters, and surgical specimens on a pcBCT scanner have been completed. Comparative evaluation of surgical specimens showed that pcBCT outperformed mammography and digital breast tomosynthesis with respect to 3D spatial resolution, detectability of calcifications, and soft tissue delineation. Major barriers to widespread clinical use of BCT relate to radiation dose, imaging of microcalcifications, and adequate coverage of breast tissue near the chest wall. Adequate chest wall coverage is also technically challenging but recent progress in x-ray tube, detector and table design now enables full breast coverage in the majority of patients. At this time, BCT has been deemed to be suitable for diagnostic imaging but not yet for screening. The mean glandular dose (MGD) from BCT has been reported to be between 5.7 to 27.8 mGy, and this range is comparable to, and within the range of, the MGD of 2.6 to 31.6 mGy in diagnostic mammography. In diagnostic studies, the median MGD from BCT and mammography were 12.6 and 11.1 mGy, respectively [Vedantham et al., Phys Med Biol. 58: 7921–36, 2013]. Moreover, in diagnostic imaging of the breast the location of the lesion is known and therefore characterization and not detection is by far the primary consideration. The role of bCT is particularly compelling for diagnostic imaging of the breast because it may replace in part the multiple mammographic views of the breast under vigorous compression. Other non-screening potential applications of bCT include the assessment of response to neoadjuvant therapy [Vedantham et al., J Clin Imaging Sci 4, 64, 2014] and pre-surgical evaluation. Learning Objectives: To understand the metrics used to evaluate screening and diagnostic imaging To understand the benefits and limitations of current clinical modalities To understand how breast CT can improve over current clinical modalities To note the early attempts to translate breast CT to the clinic in 1970s-1990s To understand the recent developments in low-dose cone-beam breast CT To understand the recent developments in photon-counting breast CT To understand the radiation dose, clinical translation, and recent developments in diagnostic imaging with breast CT Supported in part by NIH grants R21 CA134128, R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH or the NCI.; S. Vedantham, Funding sources: Supported in part by NIH/NCI grants R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH/NCI. Disclosures: Research collaboration with Koning Corporation, West Henrietta, NY. Conflicts of Interest: J. Boone, This research was supported in part by NIH grant R01CA181081; W. Kalender, WK is founder and CEO of CT Imaging GmbH Erlangen, Germany.; A. Karellas, NIH R21 CA134128, R01 CA128906, and R01 CA195512 and Research collaboration with Koning Corporation.

60 APPLIED LIFE SCIENCES↗

WE-FG-207A-02: Why We Need Breast CT? - Clinical Perspective

Mammography-based screening has been a valuable imaging tool for the early detection of non-palpable lesions and has contributed to significant reduction in breast cancer associated mortality. However, the breast imaging community recognizes that mammography is not ideal, and in particular is inferior for women with dense breasts. Also, the 2-D projection of a 3-D organ results in tissue superposition contributing to false-positives. The sensitivity of mammography is breast-density dependent. Its sensitivity, especially in dense breasts, is low due to overlapping tissue and the fact that normal breast tissue, benign lesions and breast cancers all have similar “densities”, making lesion detection more difficult. We ideally need 3-D imaging for imaging the 3-D breast. MRI is 3-D, whole breast ultrasound is 3-D, digital breast tomosynthesis is called 3-D but is really “pseudo 3-D” due to poor resolution along the depth-direction. Also, and importantly, we need to be able to administer intravenous contrast agents for optimal imaging, similar to other organ systems in the body. Dedicated breast CT allows for 3-D imaging of the uncompressed breast. In current designs, the patient is positioned prone on the table and the breast is pendant through an aperture and the scan takes approximately 10 seconds [O’Connell et al., AJR 195: 496–509, 2010]. Almost on the heels of the invention of CT itself, work began on the development of dedicated breast CT. These early breast CT systems were used in clinical trials and the results from comparative performance evaluation of breast CT and mammography for 1625 subjects were reported in 1980 [Chang et al., Cancer 46: 939–46, 1980]. However, the technological limitations at that time stymied clinical translation for decades. Subsequent to the landmark article in 2001 [Boone et al., Radiology 221: 657–67, 2001] that demonstrated the potential feasibility in terms of radiation dose, multiple research groups are actively investigating dedicated breast CT. The development of large-area flat-panel detectors with field-of-view sufficient to image the entire breast in each projection enabled development of flat-panel cone-beam breast CT. More recently, the availability of complimentary metal-oxide semiconductor (CMOS) detectors with lower system noise and finer pixel pitch, combined with the development of x-ray tubes with focal spot dimensions similar to mammography systems, has shown improved spatial resolution and could improve visualization of microcalcifications. These technological developments promise clinical translation of low-dose cone-beam breast CT. Dedicated photon-counting breast CT (pcBCT) systems represent a novel detector design, which provide high spatial resolution (∼ 100µm) and low mean glandular dose (MGD). The CdTe-based direct conversion detector technology was previously evaluated and confirmed by simulations and basic experiments on laboratory setups [Kalender et al., Eur Radiol 22: 1–8, 2012]. Measurements of dose, technical image quality parameters, and surgical specimens on a pcBCT scanner have been completed. Comparative evaluation of surgical specimens showed that pcBCT outperformed mammography and digital breast tomosynthesis with respect to 3D spatial resolution, detectability of calcifications, and soft tissue delineation. Major barriers to widespread clinical use of BCT relate to radiation dose, imaging of microcalcifications, and adequate coverage of breast tissue near the chest wall. Adequate chest wall coverage is also technically challenging but recent progress in x-ray tube, detector and table design now enables full breast coverage in the majority of patients. At this time, BCT has been deemed to be suitable for diagnostic imaging but not yet for screening. The mean glandular dose (MGD) from BCT has been reported to be between 5.7 to 27.8 mGy, and this range is comparable to, and within the range of, the MGD of 2.6 to 31.6 mGy in diagnostic mammography. In diagnostic studies, the median MGD from BCT and mammography were 12.6 and 11.1 mGy, respectively [Vedantham et al., Phys Med Biol. 58: 7921–36, 2013]. Moreover, in diagnostic imaging of the breast the location of the lesion is known and therefore characterization and not detection is by far the primary consideration. The role of bCT is particularly compelling for diagnostic imaging of the breast because it may replace in part the multiple mammographic views of the breast under vigorous compression. Other non-screening potential applications of bCT include the assessment of response to neoadjuvant therapy [Vedantham et al., J Clin Imaging Sci 4, 64, 2014] and pre-surgical evaluation. Learning Objectives: To understand the metrics used to evaluate screening and diagnostic imaging To understand the benefits and limitations of current clinical modalities To understand how breast CT can improve over current clinical modalities To note the early attempts to translate breast CT to the clinic in 1970s-1990s To understand the recent developments in low-dose cone-beam breast CT To understand the recent developments in photon-counting breast CT To understand the radiation dose, clinical translation, and recent developments in diagnostic imaging with breast CT Supported in part by NIH grants R21 CA134128, R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH or the NCI.; S. Vedantham, Funding sources: Supported in part by NIH/NCI grants R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH/NCI. Disclosures: Research collaboration with Koning Corporation, West Henrietta, NY. Conflicts of Interest: J. Boone, This research was supported in part by NIH grant R01CA181081; W. Kalender, WK is founder and CEO of CT Imaging GmbH Erlangen, Germany.; A. Karellas, NIH R21 CA134128, R01 CA128906, and R01 CA195512 and Research collaboration with Koning Corporation.

60 APPLIED LIFE SCIENCES↗

WE-FG-207A-04: Performance Characteristics of Photon-Counting Breast CT

Mammography-based screening has been a valuable imaging tool for the early detection of non-palpable lesions and has contributed to significant reduction in breast cancer associated mortality. However, the breast imaging community recognizes that mammography is not ideal, and in particular is inferior for women with dense breasts. Also, the 2-D projection of a 3-D organ results in tissue superposition contributing to false-positives. The sensitivity of mammography is breast-density dependent. Its sensitivity, especially in dense breasts, is low due to overlapping tissue and the fact that normal breast tissue, benign lesions and breast cancers all have similar “densities”, making lesion detection more difficult. We ideally need 3-D imaging for imaging the 3-D breast. MRI is 3-D, whole breast ultrasound is 3-D, digital breast tomosynthesis is called 3-D but is really “pseudo 3-D” due to poor resolution along the depth-direction. Also, and importantly, we need to be able to administer intravenous contrast agents for optimal imaging, similar to other organ systems in the body. Dedicated breast CT allows for 3-D imaging of the uncompressed breast. In current designs, the patient is positioned prone on the table and the breast is pendant through an aperture and the scan takes approximately 10 seconds [O’Connell et al., AJR 195: 496–509, 2010]. Almost on the heels of the invention of CT itself, work began on the development of dedicated breast CT. These early breast CT systems were used in clinical trials and the results from comparative performance evaluation of breast CT and mammography for 1625 subjects were reported in 1980 [Chang et al., Cancer 46: 939–46, 1980]. However, the technological limitations at that time stymied clinical translation for decades. Subsequent to the landmark article in 2001 [Boone et al., Radiology 221: 657–67, 2001] that demonstrated the potential feasibility in terms of radiation dose, multiple research groups are actively investigating dedicated breast CT. The development of large-area flat-panel detectors with field-of-view sufficient to image the entire breast in each projection enabled development of flat-panel cone-beam breast CT. More recently, the availability of complimentary metal-oxide semiconductor (CMOS) detectors with lower system noise and finer pixel pitch, combined with the development of x-ray tubes with focal spot dimensions similar to mammography systems, has shown improved spatial resolution and could improve visualization of microcalcifications. These technological developments promise clinical translation of low-dose cone-beam breast CT. Dedicated photon-counting breast CT (pcBCT) systems represent a novel detector design, which provide high spatial resolution (∼ 100µm) and low mean glandular dose (MGD). The CdTe-based direct conversion detector technology was previously evaluated and confirmed by simulations and basic experiments on laboratory setups [Kalender et al., Eur Radiol 22: 1–8, 2012]. Measurements of dose, technical image quality parameters, and surgical specimens on a pcBCT scanner have been completed. Comparative evaluation of surgical specimens showed that pcBCT outperformed mammography and digital breast tomosynthesis with respect to 3D spatial resolution, detectability of calcifications, and soft tissue delineation. Major barriers to widespread clinical use of BCT relate to radiation dose, imaging of microcalcifications, and adequate coverage of breast tissue near the chest wall. Adequate chest wall coverage is also technically challenging but recent progress in x-ray tube, detector and table design now enables full breast coverage in the majority of patients. At this time, BCT has been deemed to be suitable for diagnostic imaging but not yet for screening. The mean glandular dose (MGD) from BCT has been reported to be between 5.7 to 27.8 mGy, and this range is comparable to, and within the range of, the MGD of 2.6 to 31.6 mGy in diagnostic mammography. In diagnostic studies, the median MGD from BCT and mammography were 12.6 and 11.1 mGy, respectively [Vedantham et al., Phys Med Biol. 58: 7921–36, 2013]. Moreover, in diagnostic imaging of the breast the location of the lesion is known and therefore characterization and not detection is by far the primary consideration. The role of bCT is particularly compelling for diagnostic imaging of the breast because it may replace in part the multiple mammographic views of the breast under vigorous compression. Other non-screening potential applications of bCT include the assessment of response to neoadjuvant therapy [Vedantham et al., J Clin Imaging Sci 4, 64, 2014] and pre-surgical evaluation. Learning Objectives: To understand the metrics used to evaluate screening and diagnostic imaging To understand the benefits and limitations of current clinical modalities To understand how breast CT can improve over current clinical modalities To note the early attempts to translate breast CT to the clinic in 1970s-1990s To understand the recent developments in low-dose cone-beam breast CT To understand the recent developments in photon-counting breast CT To understand the radiation dose, clinical translation, and recent developments in diagnostic imaging with breast CT Supported in part by NIH grants R21 CA134128, R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH or the NCI.; S. Vedantham, Funding sources: Supported in part by NIH/NCI grants R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH/NCI. Disclosures: Research collaboration with Koning Corporation, West Henrietta, NY. Conflicts of Interest: J. Boone, This research was supported in part by NIH grant R01CA181081; W. Kalender, WK is founder and CEO of CT Imaging GmbH Erlangen, Germany.; A. Karellas, NIH R21 CA134128, R01 CA128906, and R01 CA195512 and Research collaboration with Koning Corporation.

60 APPLIED LIFE SCIENCES↗

WE-FG-207A-05: Dedicated Breast CT as a Diagnostic Imaging Tool: Physics and Clinical Feasibility

Mammography-based screening has been a valuable imaging tool for the early detection of non-palpable lesions and has contributed to significant reduction in breast cancer associated mortality. However, the breast imaging community recognizes that mammography is not ideal, and in particular is inferior for women with dense breasts. Also, the 2-D projection of a 3-D organ results in tissue superposition contributing to false-positives. The sensitivity of mammography is breast-density dependent. Its sensitivity, especially in dense breasts, is low due to overlapping tissue and the fact that normal breast tissue, benign lesions and breast cancers all have similar “densities”, making lesion detection more difficult. We ideally need 3-D imaging for imaging the 3-D breast. MRI is 3-D, whole breast ultrasound is 3-D, digital breast tomosynthesis is called 3-D but is really “pseudo 3-D” due to poor resolution along the depth-direction. Also, and importantly, we need to be able to administer intravenous contrast agents for optimal imaging, similar to other organ systems in the body. Dedicated breast CT allows for 3-D imaging of the uncompressed breast. In current designs, the patient is positioned prone on the table and the breast is pendant through an aperture and the scan takes approximately 10 seconds [O’Connell et al., AJR 195: 496–509, 2010]. Almost on the heels of the invention of CT itself, work began on the development of dedicated breast CT. These early breast CT systems were used in clinical trials and the results from comparative performance evaluation of breast CT and mammography for 1625 subjects were reported in 1980 [Chang et al., Cancer 46: 939–46, 1980]. However, the technological limitations at that time stymied clinical translation for decades. Subsequent to the landmark article in 2001 [Boone et al., Radiology 221: 657–67, 2001] that demonstrated the potential feasibility in terms of radiation dose, multiple research groups are actively investigating dedicated breast CT. The development of large-area flat-panel detectors with field-of-view sufficient to image the entire breast in each projection enabled development of flat-panel cone-beam breast CT. More recently, the availability of complimentary metal-oxide semiconductor (CMOS) detectors with lower system noise and finer pixel pitch, combined with the development of x-ray tubes with focal spot dimensions similar to mammography systems, has shown improved spatial resolution and could improve visualization of microcalcifications. These technological developments promise clinical translation of low-dose cone-beam breast CT. Dedicated photon-counting breast CT (pcBCT) systems represent a novel detector design, which provide high spatial resolution (∼ 100µm) and low mean glandular dose (MGD). The CdTe-based direct conversion detector technology was previously evaluated and confirmed by simulations and basic experiments on laboratory setups [Kalender et al., Eur Radiol 22: 1–8, 2012]. Measurements of dose, technical image quality parameters, and surgical specimens on a pcBCT scanner have been completed. Comparative evaluation of surgical specimens showed that pcBCT outperformed mammography and digital breast tomosynthesis with respect to 3D spatial resolution, detectability of calcifications, and soft tissue delineation. Major barriers to widespread clinical use of BCT relate to radiation dose, imaging of microcalcifications, and adequate coverage of breast tissue near the chest wall. Adequate chest wall coverage is also technically challenging but recent progress in x-ray tube, detector and table design now enables full breast coverage in the majority of patients. At this time, BCT has been deemed to be suitable for diagnostic imaging but not yet for screening. The mean glandular dose (MGD) from BCT has been reported to be between 5.7 to 27.8 mGy, and this range is comparable to, and within the range of, the MGD of 2.6 to 31.6 mGy in diagnostic mammography. In diagnostic studies, the median MGD from BCT and mammography were 12.6 and 11.1 mGy, respectively [Vedantham et al., Phys Med Biol. 58: 7921–36, 2013]. Moreover, in diagnostic imaging of the breast the location of the lesion is known and therefore characterization and not detection is by far the primary consideration. The role of bCT is particularly compelling for diagnostic imaging of the breast because it may replace in part the multiple mammographic views of the breast under vigorous compression. Other non-screening potential applications of bCT include the assessment of response to neoadjuvant therapy [Vedantham et al., J Clin Imaging Sci 4, 64, 2014] and pre-surgical evaluation. Learning Objectives: To understand the metrics used to evaluate screening and diagnostic imaging To understand the benefits and limitations of current clinical modalities To understand how breast CT can improve over current clinical modalities To note the early attempts to translate breast CT to the clinic in 1970s-1990s To understand the recent developments in low-dose cone-beam breast CT To understand the recent developments in photon-counting breast CT To understand the radiation dose, clinical translation, and recent developments in diagnostic imaging with breast CT Supported in part by NIH grants R21 CA134128, R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH or the NCI.; S. Vedantham, Funding sources: Supported in part by NIH/NCI grants R01 CA128906 and R01 CA195512. The contents are solely the responsibility of the authors and do not reflect the official views of the NIH/NCI. Disclosures: Research collaboration with Koning Corporation, West Henrietta, NY. Conflicts of Interest: J. Boone, This research was supported in part by NIH grant R01CA181081; W. Kalender, WK is founder and CEO of CT Imaging GmbH Erlangen, Germany.; A. Karellas, NIH R21 CA134128, R01 CA128906, and R01 CA195512 and Research collaboration with Koning Corporation.

60 APPLIED LIFE SCIENCES↗

Status Update - Installation and Operation of GeoMelt{sup R} ICV{sup TM} Process in the NNL's Central Laboratory on the Sellafield Site - 16410

Thermal treatment of nuclear waste in the UK has seen much renewed interest recently, owing to the advantages that can be gained in terms of reduced waste volumes, compatibility with reactive metals and organics and its ability to treat mixed generic wastes. Vitrification is a treatment option which destroys organics and some hazardous inorganics such as asbestos, reduces wasteform volume, and produces a robust leach resistant wasteform. Kurion's GeoMelt{sup R} In-Container Vitrification (ICV){sup TM} is a vitrification process where the treatment vessel can serve as an interim-storage, transport, and final long-term storage vessel - thus negating the need to pour glass into a separate container, effectively leading to a much simpler system than traditional waste melters. The UK's National Nuclear Laboratory (NNL) and Kurion have entered into a joint project to deploy an active waste ICV{sup TM} plant based on Kurion's GeoMelt{sup R} technology, at NNL's flagship Central Laboratory on the Sellafield site. NNL is the UK's national laboratory for civil nuclear science and technology, providing advice to government, protecting key skills, supporting industry and delivering national nuclear programs. NNL is bringing the Kurion GeoMelt{sup R} process alongside its existing capabilities in thermal waste treatment. Kurion provides technology solutions to minimize and stabilize nuclear and hazardous waste through its families of technologies: access, separation and stabilization processes. The GeoMelt{sup R} plant being installed at the NNL's Central Laboratory creates a platform to evaluate the vitrification technology for the variety of wastes from the NDA estate and creates a treatment path for problematic waste streams that currently have no disposition pathway. With the diverse facilities under NNL management coupled with the NNL's ability to import wastes from within the UK and Europe, this arrangement with Kurion provides waste owners with treatment disposition pathways for problematic wastes. The Kurion / NNL team completed non-radioactive commissioning of a GeoMelt{sup R} ICV{sup TM} treatment system in 2015. Commissioning consisted of performing two tests at NNL's Workington Laboratory. Commissioning Test 1 involved vitrification of 367 kg of glass frit over the course of approximately 18 hours. Commissioning Test 2 consisted of processing 470 kg of soil and additives in approximately 27 hours. The soil processed in the second test was non-radioactive soil from Sellafield and was used as an analog for radioactive soil to be processed during radioactive commissioning at the Central Laboratory at Sellafield. All commissioning test goals were easily achieved and all subsystems operated as designed. Radioactive commissioning will be carried out in early 2016. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Joint Test Protocol for Validation of Alternative Low-Emission Surface Preparation/Depainting Technologies for Structural Steel

Headquarters National Aeronautics and Space Administration (NASA) chartered the Acquisition Pollution Prevention (AP2) Office to coordinate agency activities affecting pollution prevention issues identified during system and component acquisition and sustainment processes. The primary objectives of the AP2 Office are to: (1) Reduce or eliminate the use of hazardous materials (HazMats) or hazardous processes at manufacturing, remanufacturing, and sustainment locations. (2) A void duplication of effort in actions required to reduce or eliminate HazMats through joint center cooperation and technology sharing. This project will identify, evaluate and approve alternative surface preparation technologies for use at NASA and Air Force Space Command (AFSPC) installations. Materials and processes will be evaluated with the goal of selecting those processes that will improve corrosion protection at critical systems, facilitate easier maintenance activity, extend maintenance cycles, eliminate flight hardware contamination and reduce the amount of hazardous waste generated. This Joint Test Protocol (JTP) contains the critical requirements and tests necessary to qualify alternative Low-Emission Surface Preparation/Depainting Technologies for Structural Steel Applications. These tests were derived from engineering, performance, and operational impact (supportability) requirements defined by a consensus of NASA and Air Force Space Command (AFSPC) participants. The Field Test Plan (FTP), entitled Joint Test Protocol for Validation of Alternative Low Emission Surface Preparation/Depainting Technologies for Structural Steel, prepared by ITB, defines the field evaluation and testing requirements for validating alternative surface preparation/depainting technologies and supplements the JTP.

Lewis, Pattie↗

Socially-aware evaluation framework for transportation

Technological advancements are rapidly changing traffic management in cities. Navigation applications, in particular, have impacted cities in many ways by rerouting traffic. As different routing strategies distribute traffic differently, understanding these disparities across multiple city-relevant dimensions is extremely important for decision-makers. We develop a multi-themed framework called Socially- Aware Evaluation Framework for Transportation (SAEF), which assists in understanding how traffic routing and the resultant dynamics affect cities. The framework is presented for four Bay Area cities, for which we compare three routing strategies - user equilibrium travel time, system optimal travel time, and system optimal fuel. The results demonstrate that many neighborhood impacts, such as traffic load on residential streets and around minority schools, degraded with the system-optimal travel time and fuel routing in comparison to the user-equilibrium travel time routing. The findings also show that all routing strategies subject the city's disadvantaged neighborhoods to disproportionate traffic exposure. Our intent with this work is to provide an evaluation framework that enables reflection on the consequences of traffic routing and management strategies, allowing city planners to recognize the trade-offs and potential unintended consequences.

99 GENERAL AND MISCELLANEOUS↗

Treatment of Produced Water from Carbon Sequestration Sites for Water Reuse and Mineral Recovery

Southern Research along with Advanced Resources International, Inc. (ARI), Heartland Technology Partners, LLC (Heartland), New Logic Research, Inc. (New Logic), and Mr. Michael N. DiFilippo, Consultant developed a concept for an on-site strategy and design for management of produced water from CO 2 sequestration sites for maximum water reuse. When CO 2 is injected into deep saline aquifers, it may be necessary to produce water from the reservoir to reduce reservoir pressure. The New Logic Research, vibratory shear enhanced process (VSEP) membrane technology, and Heartland Technology Partners, low momentum-high turbulence (LM-HT) evaporation technology was selected for evaluation for treating this produced water from a 530 MW natural gas combined cycle (NGCC) power plant by utilizing waste heat from the plant to drive the evaporation process. The technology was also evaluated for application to a coal-fired power plant in lieu of the NGCC power plant. The results from the project show that the application of the proposed technology to the 530 MW NGCC power plant scenario could be feasible. The results indicate that formation water TDS has a very large impact on the technical and economic feasibility of the process. One advantage of formations with low TDS water is that the VSEP membrane can be utilized to pre-concentrate the produced water upstream of the LM-HT. The results indicate that a significant portion of the exhaust gas from the NGCC power plant will have to be utilized to provide waste heat for the LM-HT evaporator; however, less will be required with low-TDS formation water. The CAPEX costs for LM-HT for all three formations (97.8USD to 122.7USD MM/year) and VSEP plus LM-HT (106.6USD MM/year) for the Keg River formation is high in cost but lower than all technology compared including crystallization, VSEP plus crystallization, FO plus LM-HT, VCE plus LM-HT, and VCE plus crystallization. The OPEX for the LM-HT for all three formations (6.33USD to 7.97USD MM/year) and VSEP plus LM-HT (13.29USD MM/year) for the Keg River formation is lower than crystallization, VSEP plus crystallization, FO plus LM-HT, and FO plus crystallization. Only VCE plus LM-HT and VCE plus crystallization have a comparable OPEX costs to LM-HT for all three formation and VSEP plus LM-HT for the Keg River formation. The coal-fired power plant comparison showed that it is not feasible to apply the technology to that type of fossil fuel plant.

04 OIL SHALES AND TAR SANDS↗

Evaluation of Representative Smart Grid Investment Project Technologies: Demand Response

This document is one of a series of reports estimating the benefits of deploying technologies similar to those implemented on the Smart Grid Investment Grant (SGIG) projects. Four technical reports cover the various types of technologies deployed in the SGIG projects, distribution automation, demand response, energy storage, and renewables integration. A fifth report in the series examines the benefits of deploying these technologies on a national level. This technical report examines the impacts of a limited number of demand response technologies and implementations deployed in the SGIG projects.

32 ENERGY CONSERVATION, CONSUMPTION, AND UTILIZATI↗

Design, process development, manufacture, test and evaluation of boron-aluminum for space shuttle components

A multi phase boron-aluminum design and evaluation program for space shuttle components was conducted, culminating in the fabrication of a 1.22 m (48 inch) x 1.83 m (72 inch) boron-aluminum compression panel capable of distributing a point load of 1555 kN (350,000 lbs) into a uniform running load at a temperature of 589 K (600 F). This panel was of the skin-stringer construction with two intermediate frame supports; seven unidirectional stringers varied in thickness from 5 plies to 52 plies and the skin was contoured to thicknesses ranging from 10 plies to 62 plies. Both the stringers and the skin incorporated Ti-6Al-4V titanium interleaves to increase bearing and in-plane shear strength. The discrete program phases were materials evaluation, design studies, process technology development, fabrication and assembly, and test and evaluation.

Garrett, R. A.↗

KEY DESIGN REQUIREMENTS FOR THE HIGH TEMPERATURE GAS-COOLED REACTOR NUCLEAR HEAT SUPPLY SYSTEM

Key requirements that affect the design of the high temperature gas-cooled reactor nuclear heat supply system (HTGR-NHSS) as the NGNP Project progresses through the design, licensing, construction and testing of the first of a kind HTGR based plant are summarized. These requirements derive from pre-conceptual design development completed to-date by HTGR Suppliers, collaboration with potential end users of the HTGR technology to identify energy needs, evaluation of integration of the HTGR technology with industrial processes and recommendations of the NGNP Project Senior Advisory Group.

42 ENGINEERING↗

Spatial impacts of technological innovations on the levelized cost of energy for offshore wind power plants in the United States

Recent studies predict significant decreases in the future levelized cost of energy (LCOE) of offshore wind energy, much of which is attributed to anticipated cost reductions from technological innovation. This study evaluates the spatial variability of LCOE caused by technology-induced decreases in a range of capital, operational, and financial cost categories. A spatial cost model of fixed-bottom and floating offshore wind plants is used to model the impact across thousands of potential United States sites. A specified change in an individual turbine subsystem cost produces a range of LCOE outcomes due to the varying geospatial characteristics of the considered sites and the nonlinear, interactive dependency on these input parameters; for example, a 10.8% improvement in net capacity factor can reduce LCOE by between 6% and 20% at different sites. This work expands upon the existing offshore wind literature, which typically evaluates cost sensitivities at a single site and does not consider the spatial variance in LCOE. The results suggest that the impact of technological innovations can be considerable and should be considered on a spatial as well as temporal basis when prioritizing technology innovation research or funding decisions to advance offshore wind technologies in the United States.

17 WIND ENERGY↗

Livingston Parish Landfill Methane Recovery Project (Feasibility Study)

The Woodside Landfill is owned by Livingston Parish, Louisiana and is operated under contract by Waste Management of Louisiana LLC. This public owner/private operator partnership is commonplace in the solid waste industry today. The landfill has been in operation since approximately 1988 and has a permitted capacity of approximately 41 million cubic yards. Based on an assumed in-place waste density of 0.94 ton per cubic yard, the landfill could have an expected design capacity of 39.3 million tons. The landfill does have an active landfill gas collection and control system (LFGCCS) in place because it meets the minimum thresholds for the New Source Performance Standards (NSPS). The initial LFGCS was installed prior to 2006 and subsequent phases were installed in 2007 and 2010. The Parish received a grant from the United States Department of Energy in 2009 to evaluate the potential for landfill gas recovery and utilization at the Woodside Landfill. This includes a technical and economic feasibility study of a project to install a landfill gas to energy (LFGTE) plant and to compare alternative technologies. The LFGTE plant can take the form of on-site electrical generation, a direct use/medium Btu option, or a high-Btu upgrade technology. The technical evaluation in Section 2 of this report concludes that landfill gas from the Woodside landfill is suitable for recovery and utilization. The financial evaluations in sections 3, 4, and 5 of this report provide financial estimates of the returns for various utilization technologies. The report concludes that the most economically viable project is the Electricity Generation option, subject to the Parish’s ability and willingness to allocate adequate cash for initial capital and/or to obtain debt financing. However, even this option does not present a solid return: by our estimates, there is a 19 year simple payback on the electricity generation option. All of the energy recovery options discussed in this report economically stressed. The primary reason for this is the recent fundamental shift in the US energy landscape. Abundant supplies of natural gas have put downward pressure on any project that displaces natural gas or natural gas substitutes. Moreover, this shift appears long-term as domestic supplies for natural gas may have been increased for several hundred years. While electricity prices are less affected by natural gas prices than other thermal projects, they are still significantly affected since much of the power in the Entergy cost structure is driven by natural gas-fired generation. Consequently, rates reimbursed by the power company based on their avoided cost structure also face downward pressure over the near and intermediate term. In addition, there has been decreasing emphasis on environmental concerns regarding the production of thermal energy, and as a result both the voluntary and mandatory markets that drive green attribute prices have softened significantly over the past couple of years. Please note that energy markets are constantly changing due to fundamental supply and demand forces, as well as from external forces such as regulations and environmental concerns. At any point in the future, the outlook for energy prices may change and could deem either the electricity generation or pipeline injection project more feasible. This report is intended to serve as the primary background document for subsequent decisions made at Parish staff and governing board levels.

09 BIOMASS FUELS↗

Thermal Hydraulics of Helium-Cooled Finger-Type Divertors at Higher Incident Heat Fluxes

Over the last decade, a number of studies at the Georgia Institute of Technology (GT) have evaluated the thermal hydraulics of the design of the helium-cooled modular divertor with multiple jets (HEMJ) originally developed at the Karlsruhe Institute of Technology. Using the GT helium loop, a test section of a single HEMJ finger heated by a radio-frequency (rf) induction heater was studied at near prototypical condition at pressures of ~10 MPa, maximum mass flow rates of 8 g/s, and maximum helium inlet temperatures Ti of 425°C. The area-averaged cooled surface temperature was estimated from embedded thermocouple measurements. This, together with the average incident heat flux q ‾ ′′ , was used to determine the average heat transfer coefficient and the corresponding Nusselt number N u ‾ over the cooled surface. The normalized pressure loss coefficient KL was determined from the pressure drop measured across the test section. The helium loop was modified last year by enclosing the test section and heater within an argon-filled stainless steel chamber to minimize oxidation of the tungsten-alloy test section. Initial results, when extrapolated to prototypical conditions, suggested that N u ‾ was about 20% higher than our previous results. However, the maximum heat flux for these results was less than 3 MW/m2 due to rf coupling with the steel chamber walls. The chamber was then recently upgraded to a glass–stainless steel enclosure with modified feedthroughs for the induction heater connections to minimize this coupling. With this upgrade, a maximum incident heat flux q ‾ ′′ = 8.1 MW/m 2 was achieved. This work presents experimental estimates and correlations for N u ‾ and K L at higher heat fluxes. These results provide greater confidence when estimating the maximum heat flux that can be accommodated by the HEMJ at fully prototypical conditions. Lastly, preliminary metrology results for the test section used to experimentally study the simplified flat design variant of the HEMJ are presented as part of an effort to resolve recently reported discrepancies between experimentally estimated and numerically simulated N u ‾ .

70 PLASMA PHYSICS AND FUSION TECHNOLOGY↗

Technology Readiness for the Smart Grid

Reluctance to adopt new technology into a utility application is understandable, given the critical nature of the infrastructure and the less-than-ideal experiences of some power companies. The authors of this paper have considered adapting the NASA approach of classifying technology readiness, but find it not quite appropriate because NASA was both the developer and the eventual user of the new technology it was evaluating, whereas a utility is ordinarily in the mode of a customer, acquiring a new product from a manufacturer. Instead of a generic scale of technology readiness, a scale of readiness is proposed specifically for the smart grid, based on the many standards that exist for the relevant technologies. In this paper we present an overall structure for organization those standards. The acceptance of new technology is organized into five SGL (Smart Grid Level) steps, numbered five through 9 to correspond approximately to the last five numbers of the NASA TRL scale. SGL 5 is a certification that the hardware and software of the technology is safe for the system into which is intended to be placed. SGL 6 is documentation that the system is safe for itself, and will have adequate reliability. It is thus clear that the steps differ from NASA’s TRL in that technology development is not required, the transition is more one of documenting already existing system readiness. Since SGL 6 describes a system that is safe for the power system and for itself, it should not be restricted from being in a pilot-scale study, and achieving SGL 7. A larger-scale demonstration in a realistic environment will demonstrate interoperability and achieve SGL 8. Only when systems are installed and operating, and when disposal plans are in place will the designation of fully operable at SGL 9 be granted.

Kirkham, Harold↗

The systematic evolution of a NASA software technology, Appendix C

A long range program is described whose ultimate purpose is to make possible the production of software in NASA within predictable schedule and budget constraints and with major characteristics such as size, run-time, and correctness predictable within reasonable tolerances. As part of the program a pilot NASA computer center will be chosen to apply software development and management techniques systematically and determine a set which is effective. The techniques will be developed by a Technology Group, which will guide the pilot project and be responsible for its success. The application of the technology will involve a sequence of NASA programming tasks graduated from simpler ones at first to complex systems in late phases of the project. The evaluation of the technology will be made by monitoring the operation of the software at the users' installations. In this way a coherent discipline for software design, production maintenance, and management will be evolved.

Deregt, M. P.↗

CFD Evaluation of Aviation Fuels for Commercial Supersonics Technology

An overview is provided of a CFD analysis of a Lean-Direct Injection (LDI) combustion concept for NASA’s Commercial Supersonic Transport (CST) program. The National Combustion Code (OpenNCC) was used to perform two-phase reacting flow computations with three different aviation fuels for UTRC’s Axially Controlled Stoichiometry (ACS) combustor at CST cruise conditions. All computations were performed with a consistent approach of mesh-generation, spray and chemical-kinetics modeling for the combustor. Emissions (EICO, EINOx) and performance characteristics were predicted with OpenNCC, to evaluate the impact of replacing Jet-A with RP2 and Iso-Paraffinic Kerosene (IPK) for supersonic combustor applications. The CFD predictions of flame structure for IPK fuel were significantly different in comparison to those of Jet-A and RP2 fuel. However, the CFD analysis predicted very similar EINOx emissions for Jet-A, RP-2 and IPK fuels. The predicted EINOx emissions for all three fuels also compared very well with measured experimental data.

gas turbine combustion↗

Low Cost Hydrogen Production Platform

A technology and design evaluation was carried out for the development of a turnkey hydrogen production system in the range of 2.4 - 12 kg/h of hydrogen. The design is based on existing SMR technology and existing chemical processes and technologies to meet the design objectives. Consequently, the system design consists of a steam methane reformer, PSA system for hydrogen purification, natural gas compression, steam generation and all components and heat exchangers required for the production of hydrogen. The focus of the program is on packaging, system integration and an overall step change in the cost of capital required for the production of hydrogen at small scale. To assist in this effort, subcontractors were brought in to evaluate the design concepts and to assist in meeting the overall goals of the program. Praxair supplied the overall system and process design and the subcontractors were used to evaluate the components and system from a manufacturing and overall design optimization viewpoint. Design for manufacturing and assembly (DFMA) techniques, computer models and laboratory/full-scale testing of components were utilized to optimize the design during all phases of the design development. Early in the program evaluation, a review of existing Praxair hydrogen facilities showed that over 50% of the installed cost of a SMR based hydrogen plant is associated with the high temperature components (reformer, shift, steam generation, and various high temperature heat exchange). The main effort of the initial phase of the program was to develop an integrated high temperature component for these related functions. Initially, six independent concepts were developed and the processes were modeled to determine overall feasibility. The six concepts were eventually narrowed down to the highest potential concept. A US patent was awarded in February 2009 for the Praxair integrated high temperature component design. A risk analysis of the high temperature component was conducted to identify any potential design deficiency related to the concept. The analysis showed that no fundamental design flaw existed with the concept, but additional simulations and prototypes would be required to verify the design prior to fabricating a production unit. These identified risks were addressed in detail during Phase II of the development program. Along with the models of the high temperature components, a detailed process and 3D design model of the remainder of system, including PSA, compression, controls, water treatment and instrumentation was developed and evaluated. Also, in Phase II of the program, laboratory/fullscale testing of the high temperature components was completed and stable operation/control of the system was verified. The overall design specifications and test results were then used to develop accurate hydrogen costs for the optimized system. Praxair continued development and testing of the system beyond the Phase II funding provided by the DOE through the end of 2008. This additional testing is not documented in this report, but did provide significant additional data for development of a prototype system as detailed in the Phase III proposal. The estimated hydrogen product costs were developed (2007 basis) for the 4.8 kg/h system at production rates of 1, 5, 10, 100 and 1,000 units built per year. With the low cost SMR approach, the product hydrogen costs for the 4.8 kg/h units at 50 units produced per year were approximately $3.02 per kg. With increasing the volume production to 1,000 units per year, the hydrogen costs are reduced by about 12% to $2.67 per kg. The cost reduction of only 12% is a result of significant design and fabrication efficiencies being realized in all levels of production runs through utilizing the DFMA principles. A simplified and easily manufactured design does not require large production volumes to show significant cost benefits. These costs represent a significant improvement and a new benchmark in the cost to produce small volume on-site hydrogen using existing process technologies. The cost models assume a natural gas cost of $5/MMBtu (HHV). Praxair has, in Phases I and II of this program, shown that significant improvements in cost, plant layout, system integration and overall system optimization are achievable. Phase III of the program, submitted in January 2007, was to focus on demonstrating both the technical feasibility and economic viability of the design developed in Phases I and II through a full-scale prototype design, construction, installation, analysis and operation at a hydrogen fueling station. Due to funding limitations, Phase III of the program was not approved by the DOE.

08 HYDROGEN↗